Covalent drugs target cancer protein via new linker
Thursday, September 15, 2016 - 18:01
in Health & Medicine
Inhibitors block Mcl-1 protein by reversibly binding to lysines instead of cysteines
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via